Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$16,381,318
+$2,118,489 QoQ
Shares Held
64,501
+10.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.64%
of 13F equity value
Holder Rank
#838
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONECO ADVISORS, LLC holds $43,364,399 across 12 Drug Manufacturers - General names. JNJ ranks #1 (37.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
64,501 | $16,381,318 | |
| 2 | LLY |
ELI LILLY & Co
|
6,143 | $7,368,099 | |
| 3 | ABBV |
AbbVie Inc.
|
22,944 | $5,773,628 | |
| 4 | PFE |
Pfizer Inc
|
170,546 | $4,106,747 | |
| 5 | GSK |
GSK plc
|
60,767 | $3,185,406 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,894 | $2,427,879 | |
| 7 | AMGN |
Amgen Inc
|
4,401 | $1,593,690 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
11,852 | $682,912 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,381,318 | 64,501 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $14,262,829 | 58,349 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,256,613 | 59,225 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $11,102,949 | 59,880 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,393,819 | 61,498 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,084,398 | 60,808 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $8,691,372 | 60,098 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $9,807,222 | 60,516 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $9,240,235 | 63,220 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $9,847,327 | 62,250 | Shares | Sole | 2024-07-19 | |
| 2023-12-31 | $9,704,243 | 61,913 | Shares | Sole | 2024-03-13 | |
| 2023-09-30 | $9,792,158 | 62,871 | Shares | Sole | 2024-03-13 | |
| 2023-06-30 | $10,439,346 | 63,070 | Shares | Sole | 2024-03-13 | |
| 2023-03-31 | $9,755,390 | 62,938 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,683,968 | 60,481 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $9,956,955 | 60,951 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $10,875,682 | 61,268 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $10,714,616 | 60,456 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $10,361,880 | 60,571 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $9,859,575 | 61,050 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,554,458 | 15,506 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,485,793 | 15,125 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,100,865 | 13,349 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $1,947,797 | 13,083 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,798,657 | 12,790 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,686,200 | 12,859 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||